| Stephanie Marie Callaghan, MS, CCC-SLP | |
|
2050 Voorhees Town Ctr, Voorhees, NJ 08043-1910 | |
| (855) 852-8150 | |
| Not Available |
| Full Name | Stephanie Marie Callaghan |
|---|---|
| Gender | Female |
| Speciality | Speech-language Pathologist |
| Location | 2050 Voorhees Town Ctr, Voorhees, New Jersey |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1104341049 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 235Z00000X | Speech-language Pathologist | 41YS00914300 (New Jersey) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Stephanie Marie Callaghan, MS, CCC-SLP 331 Preston Ave Apt 708, Voorhees, NJ 08043-1732 Ph: (856) 889-4344 | Stephanie Marie Callaghan, MS, CCC-SLP 2050 Voorhees Town Ctr, Voorhees, NJ 08043-1910 Ph: (855) 852-8150 |
News Archive
"Federal inspectors want to prevent drug-company executives from doing business with the U.S. government when their companies are convicted of Medicare fraud," The Washington Post reports. New guidelines from the Department of Health and Human Services say "executives can be barred from contracting with federal health programs when they knew, or if the inspector general concludes they should have known, about fraud at their firms."
Glutamine could help people with obesity reduce inflammation of fat tissue and reduce fat mass, according to a new study at Karolinska Institutet in Sweden and the University of Oxford in the U.K. The researchers also show how glutamine levels can alter gene expression in several different cell types.
Valeant Pharmaceuticals International, Inc. announced that its wholly owned subsidiary, Salix Pharmaceuticals, Inc., has received approval from the U.S. Food and Drug Administration for Xifaxan 550 mg for the treatment of IBS-D in adults.
Micromet, Inc., a biopharmaceutical company focused on the development and commercialization of next-generation antibodies for the treatment of cancer, today announced that data on its lead product candidate blinatumomab (MT103) will be reported at the 53rd Annual American Society of Hematology (ASH) Annual Meeting, to be held December 10 - 13 in San Diego, California.
Whenever you pick up a prescription at your community pharmacy, the information is entered into a computer database, which immediately checks the new prescription against your current medications and alerts pharmacists about possible interactions between drugs.
› Verified 9 days ago
Mrs. Kristen Marie Devlin, CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 443 Laurel Oak Rd, Voorhees, NJ 08043 Phone: 856-309-8508 | |
Mrs. Stephanie Weiser, MS CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 306 W Somerdale Rd, Voorhees, NJ 08043 Phone: 856-504-3150 Fax: 856-504-3157 | |
Alison Schaefer, MA CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 231 Lucas Ln Apt 11, Voorhees, NJ 08043 Phone: 856-809-3500 | |
Amanda Williams, Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 1000 Haddonfield Berlin Rd Ste 120, Voorhees, NJ 08043 Phone: 856-425-2239 | |
Mrs. Lauren S. Schwartzer, M.A. CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 306 W Somerdale Rd, Voorhees, NJ 08043 Phone: 856-504-3150 Fax: 856-504-3157 | |
Ruth Blackman, MA, CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 50 Westminster Dr, Voorhees, NJ 08043 Phone: 856-296-0794 |